Nu-Med Plus (NUMD) Equity Ratio (2016 - 2025)
Nu-Med Plus' Equity Ratio history spans 11 years, with the latest figure at 5.97 for Q4 2021.
- On a quarterly basis, Equity Ratio fell 811.4% to 5.97 in Q4 2021 year-over-year; TTM through Dec 2021 was 5.97, a 811.4% decrease, with the full-year FY2021 number at 5.97, down 811.4% from a year prior.
- Equity Ratio hit 5.97 in Q4 2021 for Nu-Med Plus, down from 1.37 in the prior quarter.
- Over the last five years, Equity Ratio for NUMD hit a ceiling of 0.84 in Q4 2020 and a floor of 8.09 in Q4 2019.
- Historically, Equity Ratio has averaged 1.58 across 5 years, with a median of 0.07 in 2018.
- Biggest five-year swings in Equity Ratio: skyrocketed 259.6% in 2018 and later plummeted 7793.8% in 2019.
- Tracing NUMD's Equity Ratio over 5 years: stood at 0.17 in 2017, then crashed by 31.63% to 0.11 in 2018, then crashed by 7153.68% to 8.09 in 2019, then skyrocketed by 110.37% to 0.84 in 2020, then tumbled by 811.4% to 5.97 in 2021.
- Business Quant data shows Equity Ratio for NUMD at 5.97 in Q4 2021, 1.37 in Q3 2021, and 0.02 in Q2 2021.